INCIDENCE OF ANEMIA IN HEART FAILURE AND RESPONSE TO IRON THERAPY
Main Article Content
Keywords
Heart failure, Anemia, Iron deficiency, Intravenous iron therapy
Abstract
Introduction: Anemia is a frequent comorbidity in patients with chronic heart failure (CHF), contributing to worsening symptoms, reduced exercise tolerance, and poor prognosis. Iron deficiency, whether absolute or functional, plays a significant role in its pathogenesis. Correction of anemia with iron supplementation has been shown to improve functional status, quality of life, and clinical outcomes. This study was undertaken to evaluate the incidence of anemia in heart failure patients and assess the hematological and clinical response to iron therapy. Material and Methods: A prospective observational study was conducted on 102 patients diagnosed with chronic heart failure admitted to a tertiary care hospital. Detailed clinical history, physical examination, and laboratory investigations including hemoglobin, hematocrit, serum ferritin, serum iron, and transferrin saturation were performed. Patients with confirmed anemia were treated with iron therapy and monitored for hematological and symptomatic improvement over a follow-up period. Data were analyzed using appropriate statistical tools. Results: Anemia was found in a substantial proportion of heart failure patients, highlighting its strong association with disease severity. Hematological parameters including hemoglobin and serum ferritin improved significantly following iron supplementation. Patients reported marked improvement in exercise tolerance, reduced fatigue, and better functional capacity. Statistical analysis confirmed the beneficial role of iron therapy in correcting anemia and alleviating symptoms, thereby improving overall quality of life in heart failure patients. Conclusion: Anemia is highly prevalent in patients with chronic heart failure and is frequently linked to iron deficiency. Timely detection and management with iron therapy lead to significant improvement in hematological indices and clinical status. Screening for anemia and iron deficiency should be incorporated into routine evaluation of CHF patients, and iron supplementation should be considered an integral part of comprehensive management.
References
2. Yang MS, Abdallah MB, Bashir Z, Khalife W. Heart Failure Beyond the Diagnosis: A Narrative Review of Patients’ Perspectives on Daily Life and Challenges. Journal of clinical medicine. 2024 Nov 29;13(23):7278.
3. Magrì D, De Martino F, Moscucci F, Agostoni P, Sciomer S. Anemia and iron deficiency in heart failure: clinical and prognostic role. Heart Failure Clinics. 2019 Jul 1;15(3):359-69.
4. Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018 Jul 3;138(1):80-98.
5. Anand IS. Heart failure and anemia: mechanisms and pathophysiology. Heart failure reviews. 2008 Dec;13(4):379-86.
6. Van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nature Reviews Cardiology. 2011 Sep;8(9):485-93.
7. Wahid M, Islam S, Sepehrvand N, Dover DC, McAlister FA, Kaul P, Ezekowitz JA. Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study. Circulation: Heart Failure. 2024 Apr;17(4):e011351.
8. Blumenstein I, Shanbhag S, Langguth P, Kalra PA, Zoller H, Lim W. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects–hypersensitivity, hypophosphatemia, and cardiovascular safety. Expert opinion on drug safety. 2021 Jul 3;20(7):757-69.
9. Stauder R, Valent P, Theurl I. Anemia at older age: etiologies, clinical implications, and management. Blood, The Journal of the American Society of Hematology. 2018 Feb 1;131(5):505-14.
10. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. Journal of the American College of Cardiology. 2002 Jun 5;39(11):1780-6.
11. Deichl A, Edelmann F. Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy. Frontiers in Cardiovascular Medicine. 2023 May 22;10:1025957.
12. Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung. 2010 Jun;60(06):399-412.
13. Szklarz M, Gontarz-Nowak K, Matuszewski W, Bandurska-Stankiewicz E. Can Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?. International Journal of Environmental Research and Public Health. 2022 Sep 22;19(19):11990.
14. Crespo‐Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge‐Caballero E, De Jonge N, Frigerio M. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure. 2018 Nov;20(11):1505-35.
15. Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, Steinbeck L, Kube J, Bekfani T, Scherbakov N, Valentova M. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. International journal of cardiology. 2016 Feb 15;205:6-12.
16. Avni T, Leibovici L, Gafter‐Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta‐analysis. European journal of heart failure. 2012 Apr;14(4):423-9.
17. Loncar G, Obradovic D, Thiele H, von Haehling S, Lainscak M. Iron deficiency in heart failure. ESC heart failure. 2021 Aug;8(4):2368-79.
18. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2011 Oct 1;60(10):1309-16.
19. Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. Jama. 2017 May 16;317(19):1958-66.
20. Elstrott B, Khan L, Olson S, Raghunathan V, DeLoughery T, Shatzel JJ. The role of iron repletion in adult iron deficiency anemia and other diseases. European journal of haematology. 2020 Mar;104(3):153-61.
21. Shah AM, Mann DL. In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. The Lancet. 2011 Aug 20;378(9792):704-12.
22. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. European heart journal. 2013 Mar 14;34(11):816-29.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. vipin Kumar Meena
PG student, Department of general medicine, GRMC Gwalior
Dr. Archana Kansal
Professor, Department of general medicine, GRMC Gwalior
Dr. Gaurav Kavi Bhargava
Assistant Professor, Department of general medicine, GRMC Gwalior
Dr. Jyoti Priyadarshni Shrivastava
Professor, Department of general medicine, GRMC Gwalior